selected publications academic article Erythrocyte-derived liposomes for the treatment of inflammatory diseases. Journal of Drug Targeting. 30:873-883. 2022 document Erythrocyte-derived liposomes asanti-inflammatory carriers 2022 Erythrocyte-based liposomes incorporating diclofenac for inflammatory diseases treatment 2019
